Quadrant Capital Group LLC Amphastar Pharmaceuticals, Inc. Transaction History
Quadrant Capital Group LLC
- $1.43 Billion
- Q4 2024
A detailed history of Quadrant Capital Group LLC transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Quadrant Capital Group LLC holds 740 shares of AMPH stock, worth $21,038. This represents 0.0% of its overall portfolio holdings.
Number of Shares
740
Previous 740
-0.0%
Holding current value
$21,038
Previous $35,000
22.86%
% of portfolio
0.0%
Previous 0.0%
Shares
18 transactions
Others Institutions Holding AMPH
# of Institutions
275Shares Held
35.2MCall Options Held
26.5KPut Options Held
7.9K-
Black Rock Inc. New York, NY5.94MShares$169 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.71MShares$77.2 Million0.0% of portfolio
-
Td Asset Management Inc1.84MShares$52.3 Million0.06% of portfolio
-
State Street Corp Boston, MA1.6MShares$45.4 Million0.0% of portfolio
-
Neuberger Berman Group LLC New York, NY1.37MShares$39.1 Million0.04% of portfolio
About Amphastar Pharmaceuticals, Inc.
- Ticker AMPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,015,200
- Market Cap $1.39B
- Description
- Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...